Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Boston Scientific Corp. shares valued at $526,029 were sold by Carruthers Wendy on Jun 03 ’24. At $75.33 per share, Carruthers Wendy sold 6,983 shares. The insider’s holdings dropped to 45,628 shares worth approximately $3.51 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mirviss Jeffrey B. sold 63,802 shares, netting a total of over 4,791,447 in proceeds. Following the sale of shares at $75.10 each, the insider now holds 28,022 shares.
Before that, Butcher Arthur C had sold 14,011 shares from its account. In a trade valued at $1,055,590, the EVP& Grp Pres, MedSurg & APAC traded Boston Scientific Corp. shares for $75.34 each. Upon closing the transaction, the insider’s holdings decreased to 14,011 shares, worth approximately $1.56 million.
As published in their initiating research note from Goldman on May 30, 2024, Boston Scientific Corp. [BSX] has been a Buy and the price target has been revised to $90. Analysts at Mizuho upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early February. As of July 19, 2023, Robert W. Baird has initiated its “an Outperform” rating for BSX. Earlier on June 30, 2023, CL King initiated its rating. Their recommendation was “a Buy” for BSX stock.
Analyzing BSX Stock Performance
Over the course of the year, Boston Scientific Corp. shares have jumped approximately 33.19%. Shares of the company reached a 52-week high of $77.99 on 06/24/24 and a 52-week low of $57.11 on 01/02/24. A 50-day SMA is recorded $74.32, while a 200-day SMA reached $62.82. Nevertheless, trading volume fell to 4.2 million shares from 6.01 million shares the previous day.
Support And Resistance Levels for Boston Scientific Corp. (BSX)
According to the 24-hour chart, there is a support level at 76.60, which, if violated, would cause prices to drop to 76.20. In the upper region, resistance lies at 77.45. The next price resistance is at 77.90. RSI (Relative Strength Index) is 57.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.18, which suggests the price will decrease in the coming days. Percent R is at 37.93%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
